Image may differ
AESKULISA®
Reference:
6063
Designation:
Parvovirus B19 IgM
Intended use:

The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgM
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Virus-like particles (VLPs) derived from recombinant VP2
produced in insect cells infected with baculovirus
AESKULISA®

6063

Parvovirus B19 IgM

Image may differ
Intended use:

The AESKULISA® Parvovirus B19 IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Parvovirus B19. The AESKULISA® Parvovirus B19 IgM supports the detection of acute infections. The AESKULISA® Parvovirus B19 IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made taking into account all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgM
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Virus-like particles (VLPs) derived from recombinant VP2
produced in insect cells infected with baculovirus
Downloads
All related documents and information clearly summarized

Instructions for Use

Safety Data Sheet